Evidence map›Paper›PMID 38058397›Full record

ReviewWorld journal of cardiology2023

Cardiovascular implications of inflammatory bowel disease: An updated review.

Arshia Bhardwaj, Arshdeep Singh, Vandana Midha, Ajit Sood, Gurpreet Singh Wander, Bishav Mohan, Akash Batta

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Arshia BhardwajDepartment of Gastroenterology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Arshdeep SinghDepartment of Gastroenterology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Vandana MidhaDepartment of Internal Medicine, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Ajit SoodDepartment of Gastroenterology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Gurpreet Singh WanderDepartment of Cardiology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Bishav MohanDepartment of Cardiology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Akash BattaDepartment of Cardiology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India. akashbatta02@gmail.com.
Dayanand Medical College & Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging data highlights the heightened risk of atherosclerotic cardiovascular diseases (ASCVD) in patients with chronic inflammatory disorders, particularly those afflicted with inflammatory bowel disease (IBD). This review delves into the epidemiological connections between IBD and ASCVD, elucidating potential underlying mechanisms. Furthermore, it discusses the impact of current IBD treatments on cardiovascular risk. Additionally, the cardiovascular adverse effects of novel small molecule drugs used in moderate-to-severe IBD are investigated, drawing parallels with observations in patients with rheumatoid arthritis. This article aims to comprehensively evaluate the existing evidence supporting these associations. To achieve this, we conducted a meticulous search of PubMed, spanning from inception to August 2023, using a carefully selected set of keywords. The search encompassed topics related to IBD, such as Crohn's disease and ulcerative colitis, as well as ASCVD, including coronary artery disease, cardiovascular disease, atrial fibrillation, heart failure, conduction abnormalities, heart blocks, and premature coronary artery disease. This review encompasses various types of literature, including retrospective and prospective cohort studies, clinical trials, meta-analyses, and relevant guidelines, with the objective of providing a comprehensive overview of this critical intersection of inflammatory bowel disease and cardiovascular health.

Indexed as

Cardiovascular disordersChronic inflammationEndothelial dysfunctionInflammatory bowel diseasesmyocarditisOxidative stressPericarditisThromboembolism

Identifiers

PMID38058397
PMCPMC10696203
OpenAlexW4388920947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.